Perceptic
It builds an AI operating system for pharmaceutical companies, targeting AI-enabled workflows and infrastructure for drugmakers.
Overview
Perceptic is developing an AI operating system for the pharmaceutical industry, positioning its product as infrastructure for pharma companies. Its stated focus is on the operating layer that the sector has been missing, rather than a general-purpose AI tool. The company is led by an ex-Palantir team, a background that differentiates its positioning around complex enterprise software. Perceptic raised a $12 million seed round in May 2026, its only disclosed financing to date.
Funding History
Ex-Palantir team bags $12M seed to build the AI operating system pharma has been missing
Frequently Asked Questions
- How much funding does AI Funding track for Perceptic?
- AI Funding tracks $12M for Perceptic across 1 funding round in this database.
- Who are Perceptic's investors?
- Perceptic's investors include Accel, Air Street Capital, Elder Gull.
- What does Perceptic do?
- Perceptic is developing an AI operating system for the pharmaceutical industry, positioning its product as infrastructure for pharma companies. Its stated focus is on the operating layer that the sector has been missing, rather than a general-purpose AI tool. The company is led by an ex-Palantir team, a background that differentiates its positioning around complex enterprise software. Perceptic raised a $12 million seed round in May 2026, its only disclosed financing to date.
- Where is Perceptic headquartered?
- Perceptic is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.